Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition

Journal of Biological Chemistry

Volumn 287, Issue 8, 2012, Pages 5819-5832

  Xiong, Hua ^a   Hong, Jie ^a   Du, Wan ^a   Lin, Yan Wei ^a   Ren, Lin Lin ^a   Wang, Ying Chao ^a   Su, Wen Yu ^a   Wang, Ji Lin ^a   Cui, Yun ^a   Wang, Zhen Hua ^a   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL INVASION; CHEMOSENSITIVITY; COLORECTAL CANCER; COLORECTAL CARCINOMA; DOWN-REGULATION; E-CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FLUOROURACIL; INVASIVENESS; KEY COMPONENT; LYMPH NODE; METASTATIC DISEASE; OVER-EXPRESSION; SIGNAL TRANSDUCERS; VIMENTIN;

CELL DEATH; CHEMICAL ACTIVATION; PATHOLOGY;

GLYCOPROTEINS;

FLUOROURACIL; NERVE CELL ADHESION MOLECULE; ONCOPROTEIN; PROTEIN ZEB1; STAT3 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; DRUG SENSITIVITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; METASTASIS POTENTIAL; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

APOPTOSIS; BASE SEQUENCE; CADHERINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; HOMEODOMAIN PROTEINS; HUMANS; JANUS KINASES; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 84863115473     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.295964     Document Type: Article

References (50)

1. Bates, R. C., and Mercurio, A. M. (2005) The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4, 365-370
2. Markowitz, S. D., Dawson, D. M., Willis, J., and Willson, J. K. (2002) Focus on colon cancer. Cancer Cell 1, 233-236
3. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890
4. Hay, E. D. (1995) An overview of epithelio-mesenchymal transformation. Acta Anat. 154, 8-20
5. Savagner, P. (2001) Leaving the neighborhood. Molecular mechanisms involved during epithelial-mesenchymal transition. BioEssays 23, 912-923
6. Thiery, J. P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746
7. Arima, Y., Inoue, Y., Shibata, T., Hayashi, H., Nagano, O., Saya, H., and Taya, Y. (2008) Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res. 68, 5104-5112
8. Papageorgis, P., Lambert, A. W., Ozturk, S., Gao, F., Pan, H., Manne, U., Alekseyev, Y. O., Thiagalingam, A., Abdolmaleky, H. M., Lenburg, M., and Thiagalingam, S. (2010) Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 70, 968-978
9. Arias, A. M. (2001) Epithelial mesenchymal interactions in cancer and development. Cell 105, 425-431
10. Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., and Moses, H. L. (2001) Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27-36
11. Ellenrieder, V., Hendler, S. F., Boeck, W., Seufferlein, T., Menke, A., Ruhland, C., Adler, G., and Gress, T. M. (2001) Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res. 61, 4222-4228
12. Joyce, T., Cantarella, D., Isella, C., Medico, E., and Pintzas, A. (2009) A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. Clin. Exp. Metastasis 26, 569-587
13. Gulhati, P., Bowen, K. A., Liu, J., Stevens, P. D., Rychahou, P. G., Chen, M., Lee, E. Y., Weiss, H. L., O'Connor, K. L., Gao, T., and Evers, B. M. (2011) mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 71, 3246-3256
14. Cottonham, C. L., Kaneko, S., and Xu, L. (2010) miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J. Biol. Chem. 285, 35293-35302
15. Kalogeropoulou, M., Voulgari, A., Kostourou, V., Sandaltzopoulos, R., Dikstein, R., Davidson, I., Tora, L., and Pintzas, A. (2010) TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin α6 and cancer cell migration properties. Mol. Cancer Res. 8, 554-568
16. Spano, J. P., Milano, G., Rixe, C., and Fagard, R. (2006) JAK/STAT signaling pathway in colorectal cancer. A new biological target with therapeutic implications. Eur. J. Cancer 42, 2668-2670
17. Lassmann, S., Schuster, I., Walch, A., Göbel, H., Jütting, U., Makowiec, F., Hopt, U., and Werner, M. (2007) STAT3 mRNA and protein expression in colorectal cancer. Effects on STAT3-inducible targets linked to cell survival and proliferation. J. Clin. Pathol. 60, 173-179
18. Xiong, H., Zhang, Z. G., Tian, X. Q., Sun, D. F., Liang, Q. C., Zhang, Y. J., Lu, R., Chen, Y. X., and Fang, J. Y. (2008) Inhibition of JAK1,2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10, 287-297
19. Yamashita, S., Miyagi, C., Carmany-Rampey, A., Shimizu, T., Fujii, R., Schier, A. F., and Hirano, T. (2002) Stat3 controls cell movements during zebrafish gastrulation. Dev. Cell 2, 363-375
20. Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., and Takeda, J. (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 18, 4657-4668
21. Ferrand, A., Kowalski-Chauvel, A., Bertrand, C., Pradayrol, L., Fourmy, D., Dufresne, M., and Seva, C. (2004) Involvement of JAK2 upstream of the PI 3-kinase in cell-cell adhesion regulation by gastrin. Exp. Cell Res. 301, 128-138
22. Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br. J. Cancer 100, 134-144
23. Perez-Moreno, M., Jamora, C., and Fuchs, E. (2003) Sticky business. Orchestrating cellular signals at adherens junctions. Cell 112, 535-548
24. Qiao, Y., Jiang, X., Lee, S. T., Karuturi, R. K., Hooi, S. C., and Yu, Q. (2011) FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer Res. 71, 3076-3086
25. Ren, D., Minami, Y., and Nishita, M. (2011) Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes Cells 16, 304-315
26. Gire, V., Roux, P., Wynford-Thomas, D., Brondello, J. M., and Dulic, V. (2004) DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J. 23, 2554-2563
27. Lu, R., Wang, X., Chen, Z. F., Sun, D. F., Tian, X. Q., and Fang, J. Y. (2007) Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J. Biol. Chem. 282, 12249-12259
28. Morita, Y., Naka, T., Kawazoe, Y., Fujimoto, M., Narazaki, M., Nakagawa, R., Fukuyama, H., Nagata, S., and Kishimoto, T. (2000) Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI- 1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor α-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 97, 5405-5410
29. Wang, Y. Y., Zhou, G. B., Yin, T., Chen, B., Shi, J. Y., Liang, W. X., Jin, X. L., You, J. H., Yang, G., Shen, Z. X., Chen, J., Xiong, S. M., Chen, G. Q., Xu, F., Liu, Y. W., Chen, Z., and Chen, S. J. (2005) AML1-ETO and C-KIT mutation/ overexpression in t(8;21) leukemia. Implication in stepwise leukemogenesis and response to Gleevec. Proc. Natl. Acad. Sci. U.S.A. 102, 1104-1109
30. Hecht, M., Papoutsi, M., Tran, H. D., Wilting, J., and Schweigerer, L. (2004) Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res. 64, 6109-6118
31. Fu, X., Beer, D. G., Behar, J., Wands, J., Lambeth, D., and Cao, W. (2006) cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J. Biol. Chem. 281, 20368-20382
32. Jäättelä, M. (1999) Escaping cell death. Survival proteins in cancer. Exp. Cell Res. 248, 30-43
33. Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T., and Yoshikawa, H. (2005) Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 24, 6406-6417
34. Zhang, F., Li, C., Halfter, H., and Liu, J. (2003) Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Oncogene 22, 894-905
35. Alvarez, J. V., Greulich, H., Sellers, W. R., Meyerson, M., and Frank, D. A. (2006) Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor. Cancer Res. 66, 3162-3168
36. Cavallaro, U., Liebner, S., and Dejana, E. (2006) Endothelial cadherins and tumor angiogenesis. Exp. Cell Res. 312, 659-667
37. Blaschuk, O. W., and Devemy, E. (2009) Cadherins as novel targets for anti-cancer therapy. Eur. J. Pharmacol. 625, 195-198
38. Jeanes, A., Gottardi, C. J., and Yap, A. S. (2008) Cadherins and cancer.How does cadherin dysfunction promote tumor progression? Oncogene 27, 6920-6929
39. Makrilia, N., Kollias, A., Manolopoulos, L., and Syrigos, K. (2009) Cell adhesion molecules. Role and clinical significance in cancer. Cancer Invest. 27, 1023-1037
40. Paschos, K. A., Canovas, D., and Bird, N. C. (2009) The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell. Signal. 21, 665-674
41. Gan, Y., Shi, C., Inge, L., Hibner, M., Balducci, J., and Huang, Y. (2010) Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29, 4947-4958
42. Luna-Zurita, L., Prados, B., Grego-Bessa, J., Luxán, G., del Monte, G., Benguría, A., Adams, R. H., Pérez-Pomares, J. M., and de la Pompa, J. L. (2010) Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J. Clin. Invest. 120, 3493-3507
43. Stemmer, V., de Craene, B., Berx, G., and Behrens, J. (2008) Snail promotes Wnt target gene expression and interacts with β-catenin. Oncogene 27, 5075-5080
44. Vincent, T., Neve, E. P., Johnson, J. R., Kukalev, A., Rojo, F., Albanell, J., Pietras, K., Virtanen, I., Philipson, L., Leopold, P. L., Crystal, R. G., de Herreros, A. G., Moustakas, A., Pettersson, R. F., and Fuxe, J. (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β-mediated epithelial-mesenchymal transition. Nat. Cell Biol. 11, 943-950
45. Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V., Ramirez, N., Oberyszyn, T. M., and Hall, B. M. (2009) Interleukin-6 induces an epithelial- mesenchymal transition phenotype in human breast cancer cells. Oncogene 28, 2940-2947
46. Chen, Y. L., Lv, J., Ye, X. L., Sun, M. Y., Xu, Q., Liu, C. H., Min, L. H., Li, H. P., Liu, P., and Ding, X. (2011) Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology 53, 1708-1718
47. Nieto, M. A. (2002) The snail superfamily of zinc finger transcription factors. Nat. Rev. Mol. Cell Biol. 3, 155-166
48. Peinado, H., Olmeda, D., and Cano, A. (2007) Snail, Zeb, and bHLH factors in tumor progression. An alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428
49. Kusaba, T., Nakayama, T., Yamazumi, K., Yakata, Y., Yoshizaki, A., Inoue, K., Nagayasu, T., and Sekine, I. (2006) Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol. Rep. 15, 1445-1451
50. Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., Sommergruber, W., Schweifer, N., Wernitznig, A., Beug, H., Foisner, R., and Eger, A. (2007) The transcription factor ZEB1 (δEF1) promotes tumor cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26, 6979-6988